American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

  • Take Action to Protect Medical and Public Health Research

    In July, the Senate Appropriations Committee approved a draft spending bill that would provide nearly $31 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2014, an amount that would replace funding lost due to sequestration and provide a small increase over the FY 2012 NIH budget.

  • Urge Congress to Pass the SGR Repeal and Medicare Provider Payment Modernization Act and Provide Stable Medicare Physician Payments

    On February 6, 2014 the leadership of the House Ways and Means and Energy and Commerce Committees and the Senate Finance Committee released a bi-partisan and bicameral bill to repeal the Sustainable Growth Rate (SGR) formula that has driven annual reductions in Medicare payment for physician services. Your advocacy is needed to ensure that the legislation can be considered by the full House of Representatives and Senate before the short-term physician fee update expires on April 1, 2014.

View all action alerts
  • Potential Policy Fixes to Curb Medicare Part D Opioid Abuse

    The Medicare Payment Advisory Commission (MedPAC) is an advisory body to Congress that meets seven times a year. They offer recommendations to Congress on the various payment systems within Medicare, as well as monitor more focused topics of their choosing. During the most recent meeting on October 9, MedPAC analyzed data on opioid abuse for Medicare Part D enrollees.  Both the findings and potential policy implications could affect practicing hematologists who routinely prescribe opioids.

  • Ebola Alert

    The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and Office of the Assistant Secretary for Preparedness and Response (ASPR) continues to respond to the current Ebola outbreak in West Africa. The CDC has summarized key messages about the outbreak and the response, and it will continue to update its resources as more information becomes available.

  • Sunshine Data Released – What’s Next?

    On September 30 at around 2PM, the Centers for Medicare and Medicaid Services (CMS) publicly released the data that it had been gathering from pharmaceutical and medical device companies that detail value transfers to physicians and medical schools.  ASH has been keeping members apprised of these developments since this provision was included in the Affordable Care Act.

  • Least Costly Alternatives for Drugs in the World of Hematology

    The Medicare Payment Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to take on an issue that could be very important for hematologists and access to drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis.  ASH continues to follow this issue as part of a commitment to ensure that policies are created that give patients efficient access to important drugs while maintaining clinician decision-making and incentives for continued innovation.

View all policy news
back to top